Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer

Kerri Ann Norton, Aleksander S. Popel, Niranjan B. Pandey

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Introduction: Tumor heterogeneity is a well-established concept in cancer research. In this paper, we examine an additional type of tumor cell heterogeneity - tumor cell-surface receptor heterogeneity. Methods: We use flow cytometry to measure the frequency and numbers of cell-surface receptors on triple negative breast cancer cell lines. Results: We find two distinct populations of human triple-negative breast cancer cells MDA-MB-231 when they are grown in culture, one with low surface levels of various chemokine receptors and a second with much higher levels. The population with high surface levels of these receptors is increased in the more metastatic MDA-MB-231-luc-d3h2ln cell line. Conclusion: We hypothesize that this high cell-surface receptor population is involved in metastasis. We find that the receptor high populations can be modulated by tumor conditioned media and IL6 treatment indicating that the tumor microenvironment is important for the maintenance and sizes of these populations.

Original languageEnglish (US)
Pages (from-to)1295-1307
Number of pages13
JournalAmerican Journal of Cancer Research
Issue number4
StatePublished - 2015


  • CCR5
  • CXCR3
  • CXCR4
  • IL6
  • MDA-MB-231
  • Stem cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer'. Together they form a unique fingerprint.

Cite this